Newsroom

Recent News Releases

April 1, 2020 4/1/2020

Takeda Announces Advancement of the Operation for the Shonan Health Innovation Park (Shonan iPark)

April 1, 2020 4/1/2020

Takeda Adopts Executive Compensation Recoupment Policy

March 31, 2020 3/31/2020

Takeda Receives Positive CHMP Opinion for ADCETRIS^® (brentuximab vedotin) in Combination with CHP (Cyclophosphamide, Doxorubicin and Prednisone) for Treatment of Adult Patients with Previously Untreated Systemic Anaplastic Large Cell Lymphoma

March 23, 2020 3/23/2020

Takeda Receives Approval of Entyvio^® (Vedolizumab) in China for the Treatment of Patients with Moderate to Severe Active Ulcerative Colitis (UC) and Crohn's Disease (CD)

March 17, 2020 3/17/2020

The Lancet publishes papers from two studies of Takeda’s dengue vaccine candidate

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Coronavirus: Adjusting Our Business Approach While Serving Our Patients

Learn more

Rajeev Venkayya, President, Global Vaccine Business Unit on the latest on the Coronavirus and Takeda

Learn more

Shaping the future of healthcare: Sustainability and Davos 2020

Learn more

2019 – A Transformative Year for Takeda

Learn more

Empowering women with Chronic Idiopathic Constipation to take control of their condition

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.